MustGrow Biologics Corp.
MGROF
$0.6884
-$0.0316-4.39%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -15.56% | -91.64% | -- | 346,260.00% | 88,710.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.56% | -91.64% | -- | 346,260.00% | 88,710.26% |
| Cost of Revenue | 794.95% | -19.45% | -18.26% | -25.34% | 44.19% |
| Gross Profit | -87.65% | -98.12% | 1,616.64% | 1,483.99% | 1,754.03% |
| SG&A Expenses | 25.32% | 2.14% | 2.73% | -9.91% | -19.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.44% | -1.83% | -0.30% | -12.30% | -12.03% |
| Operating Income | -2,284.62% | -1,656.29% | 103.77% | 101.28% | 96.48% |
| Income Before Tax | -649.02% | -569.54% | 95.26% | 91.73% | 87.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -649.02% | -569.54% | 95.26% | 91.73% | 87.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -649.02% | -569.54% | 95.26% | 91.73% | 87.64% |
| EBIT | -2,284.62% | -1,656.29% | 103.77% | 101.28% | 96.48% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -616.19% | -511.50% | 97.12% | 92.53% | 87.83% |
| Normalized Basic EPS | -612.12% | -517.14% | 97.06% | 92.34% | 87.73% |
| EPS Diluted | -616.19% | -511.50% | 97.12% | 92.53% | 87.83% |
| Normalized Diluted EPS | -612.12% | -517.14% | 97.06% | 92.34% | 87.73% |
| Average Basic Shares Outstanding | 3.95% | 3.54% | 3.22% | 2.63% | 1.90% |
| Average Diluted Shares Outstanding | 3.95% | 3.54% | 3.22% | 2.63% | 1.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |